Crispr Therapeutics

Yahoo Finance • 18 hours ago

Cathie Wood buys $6.5 million of megacap tech stock

Cathie Wood has spent much of 2026 rotating among artificial intelligence winners, trimming some positions while adding to others as investors pile into the sector. The Ark Invest chief just bought shares of a megacap tech firm. In 2025,... Full story

Yahoo Finance • 2 days ago

Is CRISPR Therapeutics (CRSP) One Of The Under-The-Radar Stocks With Massive Upside For 2026?

With an analyst consensus upside of 52.3%, CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the under-the-radar stocks with massive upside for 2026.Is CRISPR Therapeutics (CRSP) One Of The Under-The-Radar Stocks With Massive Upside For 202... Full story

Yahoo Finance • 6 days ago

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?

Key Points CRISPR Therapeutics has an approved product and several gene editing medicines in development. Beam Therapeutics is exploring ways to develop safer gene-editing therapies. One of these stocks is a lot less risky than the other.... Full story

Yahoo Finance • 15 days ago

Cathie Wood sells $40.6 million of popular semiconductor stock

Cathie Wood, chief of Ark Investment Management, is known for actively trading her holdings, sometimes selling stocks during sharp market pullbacks. Semiconductor stocks experienced a major market pullback on May 15, with the iShares Semi... Full story

Yahoo Finance • 19 days ago

Roku Inc Faces Significant Reduction in Catherine Wood's Portfolio

This article first appeared on GuruFocus. Exploring the Strategic Moves of ARK's Founder in Q1 2026 Catherine Wood (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2026, providing insights into her investmen... Full story

Yahoo Finance • 19 days ago

Stocks making the biggest moves premarket: On Holding, Under Armour, GameStop, AST SpaceMobile & more

Check out the companies making headlines before the bell: Under Armour — The sportswear company slid 14% after posting a loss of 3 cents on revenue of $1.17 billion. Analysts polled by LSEG were anticipating a loss of 2 cents on revenue of... Full story

Yahoo Finance • 21 days ago

Cathie Wood buys $12.9 million of tumbling tech stock

Cathie Wood, chief of Ark Investment Management, is known for making bold bets on fast-moving tech stocks. Sometimes her trades move just as quickly as the stocks themselves. In the week that began on May 3, Wood sold millions of dollars... Full story

Yahoo Finance • 27 days ago

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first quarter reflected continued execution across CRISPR... Full story

Yahoo Finance • 28 days ago

Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?

Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls’ thesis on PGEN. Precigen, Inc.'s share was trading at $4.0200 as of April 28... Full story

Yahoo Finance • 28 days ago

Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now?

Is MLYS a good stock to buy? We came across a bullish thesis on Mineralys Therapeutics, Inc. on Valueinvestorsclub.com by conway968. In this article, we will summarize the bulls’ thesis on MLYS. Mineralys Therapeutics, Inc.'s share was tra... Full story

Yahoo Finance • 29 days ago

Is Beam Therapeutics Inc. (BEAM) A Good Stock To Buy Now?

Is BEAM a good stock to buy? We came across a bullish thesis on Beam Therapeutics Inc. on r/ValueInvesting by Significant-Pair-275. In this article, we will summarize the bulls’ thesis on BEAM. Beam Therapeutics Inc.'s share was trading at... Full story

Yahoo Finance • last month

3 Growth Stocks That Could Generate 10X Returns

The biggest payoff from investing in stocks often comes years down the road, when companies you've invested in have grown larger and become more valuable. There can be some considerable risks involving smaller, unproven businesses, but the... Full story

Yahoo Finance • last month

Cathie Wood sells $75M of surging semiconductor stock

Cathie Wood, head of Ark Investment Management, often takes advantage of market swings. That’s what she just did, selling shares of a semiconductor stock after it jumped 25% in a week. Last year, Wood’s flagship Ark Innovation ETF (ARKK)... Full story

Yahoo Finance • last month

Cathie Wood buys $2.5 million of tumbling megacap stock

Cathie Wood, head of Ark Investment Management, was relatively quiet this week, even as the S&P 500 rallied about 4.5% over the past five days. Wood made no trades on Tuesday, April 14, and Wednesday, April 15, and sold some shares of two... Full story

Yahoo Finance • 2 months ago

Want to Invest in OpenAI Before Its Blockbuster IPO? Here's How to Do It.

Key Points OpenAI is the creator of ChatGPT, which is one of the world's most popular artificial intelligence (AI) chatbots. OpenAI is a private company, so everyday investors can't directly buy its shares, but plans for an initial publi... Full story

Yahoo Finance • 2 months ago

Meet Cathie Wood's Flagship Ark Innovation ETF, Which Has Crushed the S&P 500 Over the Last 12 Months

Ark Investment Management operates a dozen exchange-traded funds (ETFs) that invest in companies that are pursuing innovations across an array of technologies. Some of these funds have a specific focus in areas like artificial intelligence... Full story

Yahoo Finance • 2 months ago

This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area

CRISPR Therapeutics(NASDAQ: CRSP) has significantly lagged broader equities over the past five years. There are several reasons for that. Challenging economic conditions have led investors to rotate their money out of somewhat speculative... Full story

Yahoo Finance • 2 months ago

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics AG ZUG, Switzerland and BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual Needham Virtual Healthcar... Full story

Yahoo Finance • 2 months ago

Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?

Investors looking for stocks that can turn a modest portfolio into a multimillion-dollar nest egg often find what they're looking for in the biotech industry. For several years, CRISPR Therapeutics(NASDAQ: CRSP) has been attracting investm... Full story

Yahoo Finance • 2 months ago

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Cathie Wood’s ARK Invest funds have delivered mixed performance in the recent period, with ARK Space & Defense Innovation ETF (ARKX [https://seekingalpha.com/symbol/ARKX]) up 1.27% and ARK Autonomous Technology & Robotics ETF (ARKQ [https:... Full story